Round The Wire: Developments and Treatment Considerations for Ophthalmologic and Retinal Diseases

In this roundtable series, a panel of ophthalmology experts discusses new advances for neovascular age-related macular degeneration, real-world treatment considerations for diabetic macular edema, and more. Moderator Ehsan Rahimy, MD, leads the dynamic conversation with Diana Do, MD; Rishi Singh, MD; Caroline Baumal, MD; and Ali Khan, MD.

Panelists Weigh in on Port Delivery Systems for Neovascular AMD Treatments

Ehsan Rahimy, MD, moderates a discussion about hands-on experience with port delivery systems for patients with neovascular AMD. Ehsan Rahimy: Let’s spend some time talking about port delivery. Has anyone had hands-on experience with it? How are the conversations going with your patients when you...

Clinical Trial Data Versus Real-World Experience for Neovascular AMD Treatments

In this segment of the round table series, moderator Ehsan Rahimy, MD, and panelists discuss the findings from and their reactions to the TENAYA and LUCERNE studies. Ehsan Rahimy: The beauty of retinal medicine is it’s a different song and dance with every patient. So, I...

Exciting Advancements Coming for Neovascular AMD

The panel discusses the advancements they are most looking forward to in the neovascular AMD space, from new treatments to cutting-edge at-home imaging modalities. Ehsan Rahimy: Tell me 1 thing you’re excited to find out in this space sometime in the next year. Is there...

Who’s Who

Moderator – Ehsan Rahimy, MD:

Retina Specialist, Palo Alto Medical Foundation, Stanford University

Dr. Ehsan Rahimy is a retina specialist practicing at the Palo Alto Medical Foundation and an adjunct faculty member at Stanford University, where he helps train surgical retinal fellows at one of the preeminent retina fellowships in the country. He completed his undergraduate degree at the University of Michigan, medical school at Baylor College of Medicine, residency at the UCLA Stein Eye Institute, and his retina fellowship at Wills Eye Hospital. He has more than 100 peer-reviewed scientific publications and has contributed to more than 150 abstracts presented at national and international ophthalmic meetings. He has a particular expertise in the interplay between technology and medicine, notably with emerging artificial intelligence and deep-learning platforms and how ongoing advancements and further integration will transform health care delivery in the future.

Caroline Baumal, MD:

Retina Specialist, New England Eye Center, Tufts Medical Center

Dr. Caroline Baumal is a professor of ophthalmology at the New England Eye Center, Tufts Medical Center, in Boston, Massachusetts. She specializes in diseases and surgery of the retina and vitreous.
Dr. Baumal is board certified by the American Board of Ophthalmology. She has received multiple awards from various societies, including the American Academy of Ophthalmology, the American Society of Retinal Surgeons (Crystal Apple Award), the Retinal Hall of Fame, and the Florida Ophthalmologic Society (Donald J. Gass Beacon of Sight Award). Recently, Dr. Baumal was given the Lifetime Achievement Award from the Vit-Buckle Society. She is on the editorial board for Retinal Cases & Brief Reports and Ophthalmic Surgery, Lasers, and Imaging Retina. Dr. Baumal has authored more than 160 publications and 28 book chapters on retinal diseases. She edited the book Current Management of Diabetic Retinopathy. Dr. Baumal is actively involved in teaching vitreoretinal fellows and residents and was previously the director of education and the residency program at the New England Eye Center.

Diana Do, MD:

Professor of Ophthalmology, Retina Surgeon, Byers Eye Institute, Stanford University

Dr. Diana Do is vice-chair of clinical affairs and professor of ophthalmology at the Byers Eye Institute, Stanford University School of Medicine. She is a leading physician-scientist who has more than 15 years of experience in clinical trials and retinal research. She has an active clinical practice and specializes in the surgical and medical treatment of retinal disorders. She has been the principal investigator and co-investigator on more than 35 clinical trials investigating novel treatments for retinal diseases, including age-related macular degeneration, diabetic macular edema and diabetic retinopathy, and retinal vein occlusion. She has authored more than 125 publications in the medical literature and has contributed to more than 25 book chapters.

Ali Khan, MD:

Retina Specialist, Wills Eye Hospital, Thomas Jefferson University

Dr. Ali Khan is a vitreoretinal surgeon at Wills Eye Hospital and assistant professor of ophthalmology at Thomas Jefferson University in Philadelphia, Pennsylvania. He received his medical degree from David Geffen School of Medicine at UCLA.

Rishi Singh, MD:

Staff Surgeon, Cleveland Clinic; President, Cleveland Clinic Martin Hospitals

Dr. Rishi Singh is a staff surgeon at the Cleveland Clinic Florida, professor of ophthalmology at the Lerner College of Medicine, and president of Cleveland Clinic Martin Hospitals in Stuart, Florida.
He specializes in the treatment of medical and surgical retinal disease such as diabetic retinopathy, retinal detachment, and age-related macular degeneration. Dr. Singh has authored more than 200 peer-reviewed publications, books, and book chapters and serves as the principal investigator of numerous national clinical trials advancing the treatment of retinal disease. Dr. Singh is the former president of the Retina World Congress and is on the board of the American Society of Retina Specialists. He has been honored with several research recognitions such as the Alpha Omega Alpha Research Award, the American Society of Retina Specialists Senior Honor Award, and the American Academy of Ophthalmology Senior Achievement Award.